Trinity Resources Inc
Alzex Neuropharma Inc., a development stage biopharmaceutical company, engages in developing therapeutics for the treatment of Alzheimer's Disease and other neurological diseases. The company was formerly known as Trinity Resources Inc. and changed its name to Alzex Neuropharma Inc. in December 2022. The company was incorporated in 1971 and is headquartered in Las Vegas, Nevada.
Market Cap & Net Worth: Trinity Resources Inc (TRRI)
Trinity Resources Inc (PINK:TRRI) has a market capitalization of $90.32K ($90.32K) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #48725 globally and #14952 in its home market, demonstrating a -25.00% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Trinity Resources Inc's stock price $0.06 by its total outstanding shares 1505270 (1.51 Million).
Trinity Resources Inc Market Cap History: 2015 to 2025
Trinity Resources Inc's market capitalization history from 2015 to 2025. Data shows change from $120.42K to $90.32K (-5.26% CAGR).
Trinity Resources Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Trinity Resources Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of TRRI by Market Capitalization
Companies near Trinity Resources Inc in the global market cap rankings as of March 18, 2026.
Key companies related to Trinity Resources Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Trinity Resources Inc Historical Marketcap From 2015 to 2025
Between 2015 and today, Trinity Resources Inc's market cap moved from $120.42K to $ 90.32K, with a yearly change of -5.26%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $90.32K | -80.20% |
| 2024 | $456.10K | +51.50% |
| 2023 | $301.05K | -9.09% |
| 2022 | $331.16K | -51.11% |
| 2021 | $677.37K | +997.56% |
| 2020 | $61.72K | -84.81% |
| 2019 | $406.42K | +1700.00% |
| 2018 | $22.58K | +26.05% |
| 2017 | $17.91K | -76.20% |
| 2016 | $75.26K | -37.50% |
| 2015 | $120.42K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Trinity Resources Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $90.32K USD |
| MoneyControl | $90.32K USD |
| MarketWatch | $90.32K USD |
| marketcap.company | $90.32K USD |
| Reuters | $90.32K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.